| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.899 | 0.003 | 0.899 | Aldehyde oxidase inhibitor | 0.209 0.1 CID_22827811 | ||
| 0.723 | 0.005 | 0.723 | 5 Hydroxytryptamine release stimulant | 0.569 0.018 CID_22827811 | ||
| 0.711 | 0.003 | 0.711 | GABA C receptor rho-3 antagonist | |||
| 0.66 | 0.004 | 0.66 | Peroxidase inhibitor | |||
| 0.643 | 0.006 | 0.715 | 5 Hydroxytryptamine release inhibitor | 0.715 0.004 CID_22827811 | CID_22827811 | |
| 0.647 | 0.03 | 0.647 | Caspase 9 stimulant | 0.604 0.035 CID_22827811 | ||
| 0.62 | 0.016 | 0.781 | Cholesterol antagonist | 0.781 0.004 CID_22827811 | CID_22827811 | |
| 0.603 | 0.003 | 0.603 | Cystathionine beta-synthase inhibitor | 0.51 0.004 CID_22827811 | ||
| 0.555 | 0.003 | 0.555 | 5 Hydroxytryptamine uptake stimulant | 0.275 0.06 CID_22827811 | ||
| 0.524 | 0.022 | 0.647 | Histamine release inhibitor | 0.647 0.007 CID_22827811 | CID_22827811 | |
| 0.51 | 0.012 | 0.51 | Superoxide dismutase inhibitor | |||
| 0.488 | 0.004 | 0.488 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.474 | 0.003 | 0.474 | Succinate dehydrogenase inhibitor | 0.248 0.023 CID_22827811 | ||
| 0.473 | 0.004 | 0.473 | Alcohol oxidase inhibitor | 0.054 0.041 CID_22827811 | ||
| 0.448 | 0.011 | 0.448 | Anesthetic general | 0.427 0.013 CID_22827811 | ||
| 0.437 | 0.003 | 0.437 | Creatine kinase inhibitor | 0.114 0.045 CID_22827811 | ||
| 0.459 | 0.027 | 0.459 | 12-Lipoxygenase inhibitor | |||
| 0.43 | 0.004 | 0.43 | Estrogen receptor beta antagonist | |||
| 0.439 | 0.013 | 0.439 | Calcium channel activator | 0.239 0.16 CID_22827811 | ||
| 0.418 | 0.008 | 0.65 | Alpha-N-acetylglucosaminidase inhibitor | 0.65 0.003 CID_22827811 | CID_22827811 | |
| 0.433 | 0.024 | 0.662 | Free radical scavenger | 0.662 0.006 CID_22827811 | CID_22827811 | |
| 0.413 | 0.004 | 0.413 | Estrogen antagonist | |||
| 0.408 | 0.009 | 0.736 | Amylase inhibitor | 0.736 0.003 CID_22827811 | CID_22827811 | |
| 0.408 | 0.017 | 0.408 | RNA-directed DNA polymerase inhibitor | 0.34 0.025 CID_22827811 | ||
| 0.427 | 0.04 | 0.427 | Streptokinase A inhibitor | |||
| 0.386 | 0.004 | 0.478 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.478 0.003 CID_22827811 | CID_22827811 | |
| 0.436 | 0.059 | 0.436 | 15-Lipoxygenase inhibitor | |||
| 0.441 | 0.068 | 0.441 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.404 | 0.037 | 0.404 | Aryl hydrocarbon receptor agonist | |||
| 0.408 | 0.042 | 0.408 | Caspase 3 stimulant | 0.398 0.045 CID_22827811 | ||
| 0.369 | 0.006 | 0.369 | GABA C receptor agonist | 0.094 0.073 CID_22827811 | ||
| 0.37 | 0.007 | 0.381 | Neurotrophic factor enhancer | 0.381 0.007 CID_22827811 | CID_22827811 | |
| 0.363 | 0.004 | 0.363 | Nitric-oxide synthase stimulant | 0.361 0.004 CID_22827811 | ||
| 0.393 | 0.04 | 0.393 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.355 | 0.005 | 0.355 | Histidine decarboxylase inhibitor | |||
| 0.385 | 0.038 | 0.708 | Antioxidant | 0.708 0.005 CID_22827811 | CID_22827811 | |
| 0.353 | 0.008 | 0.353 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.352 | 0.008 | 0.352 | Aldehyde dehydrogenase inhibitor | 0.307 0.011 CID_22827811 | ||
| 0.348 | 0.004 | 0.348 | Potassium channel large-conductance Ca-activated activator | 0.068 0.047 CID_22827811 | ||
| 0.345 | 0.007 | 0.345 | NADPH oxidase inhibitor | 0.275 0.016 CID_22827811 | ||
| 0.341 | 0.004 | 0.341 | Potassium channel (Ca-activated) activator | 0.107 0.05 CID_22827811 | ||
| 0.394 | 0.065 | 0.705 | Transcription factor NF kappa B inhibitor | 0.705 0.02 CID_22827811 | CID_22827811 | |
| 0.406 | 0.077 | 0.406 | Calcium channel L-type activator | |||
| 0.329 | 0.006 | 0.531 | NADH dehydrogenase inhibitor | 0.531 0.003 CID_22827811 | CID_22827811 | |
| 0.337 | 0.015 | 0.337 | Phospholipase C inhibitor | 0.242 0.027 CID_22827811 | ||
| 0.331 | 0.009 | 0.478 | UDP-glucose 4-epimerase inhibitor | 0.478 0.003 CID_22827811 | CID_22827811 | |
| 0.353 | 0.033 | 0.353 | Pyruvate kinase inhibitor | |||
| 0.332 | 0.015 | 0.332 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.263 0.037 CID_22827811 | ||
| 0.32 | 0.005 | 0.32 | GABA C receptor rho-2 antagonist | |||
| 0.301 | 0.005 | 0.301 | Carbonic anhydrase III inhibitor | 0.176 0.021 CID_22827811 | ||
| 0.303 | 0.008 | 0.303 | Carbonic anhydrase XV inhibitor | |||
| 0.315 | 0.021 | 0.315 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.341 | 0.054 | 0.341 | Lipoxygenase inhibitor | |||
| 0.291 | 0.005 | 0.291 | Estrogen agonist | 0.076 0.024 CID_22827811 | ||
| 0.399 | 0.114 | 0.655 | Apoptosis agonist | 0.655 0.038 CID_22827811 | CID_22827811 | |
| 0.289 | 0.004 | 0.289 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.327 | 0.043 | 0.327 | Transcription factor STAT inhibitor | |||
| 0.318 | 0.038 | 0.329 | Psychostimulant | 0.329 0.036 CID_22827811 | CID_22827811 | |
| 0.287 | 0.006 | 0.301 | Mannose-6-phosphate isomerase inhibitor | 0.301 0.005 CID_22827811 | CID_22827811 | |
| 0.292 | 0.012 | 0.292 | Cholesterol synthesis inhibitor | 0.217 0.023 CID_22827811 | ||
| 0.286 | 0.008 | 0.464 | ATPase inhibitor | 0.464 0.003 CID_22827811 | CID_22827811 | |
| 0.28 | 0.005 | 0.28 | GABA C receptor antagonist | |||
| 0.391 | 0.119 | 0.65 | Alpha-glucosidase inhibitor | 0.65 0.043 CID_22827811 | CID_22827811 | |
| 0.285 | 0.015 | 0.285 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.288 | 0.02 | 0.288 | Amyloid beta precursor protein antagonist | |||
| 0.314 | 0.047 | 0.314 | Transcription factor STAT3 inhibitor | |||
| 0.272 | 0.004 | 0.272 | 5 Hydroxytryptamine 3A agonist | |||
| 0.277 | 0.01 | 0.277 | Ferrochelatase inhibitor | |||
| 0.271 | 0.008 | 0.271 | NMDA receptor antagonist | |||
| 0.276 | 0.013 | 0.439 | Hexokinase inhibitor | 0.439 0.004 CID_22827811 | CID_22827811 | |
| 0.307 | 0.045 | 0.458 | Interleukin agonist | 0.458 0.012 CID_22827811 | CID_22827811 | |
| 0.266 | 0.004 | 0.266 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.313 | 0.051 | 0.313 | Insulysin inhibitor | |||
| 0.318 | 0.057 | 0.353 | Hypoxia-inducible factor 1 alpha inhibitor | 0.353 0.044 CID_22827811 | CID_22827811 | |
| 0.279 | 0.018 | 0.279 | Heat shock protein 90 alpha antagonist | |||
| 0.303 | 0.042 | 0.466 | DNA synthesis inhibitor | 0.466 0.016 CID_22827811 | CID_22827811 | |
| 0.305 | 0.044 | 0.305 | Amyloid beta aggregation inhibitor | 0.144 0.113 CID_22827811 | ||
| 0.294 | 0.035 | 0.294 | ErbB-1 antagonist | |||
| 0.282 | 0.023 | 0.457 | Interferon gamma antagonist | 0.457 0.008 CID_22827811 | CID_22827811 | |
| 0.262 | 0.003 | 0.262 | DOPA decarboxylase inhibitor | 0.102 0.072 CID_22827811 | ||
| 0.262 | 0.007 | 0.262 | Porphobilinogen synthase inhibitor | |||
| 0.276 | 0.022 | 0.41 | NOS3 expression enhancer | 0.41 0.008 CID_22827811 | CID_22827811 | |
| 0.278 | 0.025 | 0.465 | Melanin inhibitor | 0.465 0.008 CID_22827811 | CID_22827811 | |
| 0.279 | 0.027 | 0.279 | Mcl-1 antagonist | |||
| 0.282 | 0.032 | 0.557 | Non-steroidal antiinflammatory agent | 0.557 0.005 CID_22827811 | CID_22827811 | |
| 0.262 | 0.012 | 0.262 | Interleukin 4 antagonist | 0.179 0.03 CID_22827811 | ||
| 0.351 | 0.101 | 0.667 | Antibacterial | 0.667 0.011 CID_22827811 | CID_22827811 | |
| 0.258 | 0.009 | 0.258 | Catenin beta inhibitor | |||
| 0.297 | 0.049 | 0.297 | Interleukin antagonist | |||
| 0.32 | 0.072 | 0.508 | Vasodilator, coronary | 0.508 0.014 CID_22827811 | CID_22827811 | |
| 0.253 | 0.005 | 0.253 | Macrophage migration inhibitory factor inhibitor | |||
| 0.312 | 0.066 | 0.49 | Interleukin 2 agonist | 0.49 0.009 CID_22827811 | CID_22827811 | |
| 0.338 | 0.092 | 0.338 | Calpain 2 inhibitor | |||
| 0.278 | 0.033 | 0.278 | Dual specificity phosphatase 3 inhibitor | |||
| 0.25 | 0.006 | 0.25 | CF transmembrane conductance regulator agonist | 0.187 0.03 CID_22827811 | ||
| 0.251 | 0.009 | 0.639 | Cyclooxygenase 3 inhibitor | 0.639 0.002 CID_22827811 | CID_22827811 | |
| 0.246 | 0.004 | 0.246 | Estrogen receptor alpha agonist | |||
| 0.275 | 0.034 | 0.275 | Neuropeptide Y2 antagonist | |||
| 0.256 | 0.019 | 0.256 | Heat shock protein 90 antagonist | |||
| 0.241 | 0.005 | 0.241 | Electrolyte absorption antagonist | |||
| 0.241 | 0.008 | 0.241 | Arachidonic acid antagonist | 0.199 0.033 CID_22827811 | ||
| 0.32 | 0.087 | 0.32 | Vasodilator, peripheral | 0.297 0.099 CID_22827811 | ||
| 0.252 | 0.02 | 0.259 | Alkaline phosphatase inhibitor | 0.259 0.018 CID_22827811 | CID_22827811 | |
| 0.239 | 0.009 | 0.648 | Beta glucuronidase inhibitor | 0.648 0.003 CID_22827811 | CID_22827811 | |
| 0.246 | 0.018 | 0.246 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.285 | 0.058 | 0.752 | Hypoglycemic | 0.752 0.004 CID_22827811 | CID_22827811 | |
| 0.277 | 0.051 | 0.431 | Cyclic AMP phosphodiesterase inhibitor | 0.431 0.013 CID_22827811 | CID_22827811 | |
| 0.248 | 0.021 | 0.248 | Neurotensin receptor agonist | |||
| 0.23 | 0.004 | 0.23 | GABA aminotransferase inhibitor | 0.193 0.004 CID_22827811 | ||
| 0.229 | 0.004 | 0.229 | NMDA receptor subunit 3B antagonist | |||
| 0.227 | 0.003 | 0.227 | GABA B receptor agonist | |||
| 0.237 | 0.014 | 0.237 | Farnesoid X receptor antagonist | |||
| 0.225 | 0.004 | 0.25 | Glutamate release inhibitor | 0.25 0.004 CID_22827811 | CID_22827811 | |
| 0.221 | 0.003 | 0.221 | D-Ala-D-Ala ligase inhibitor | |||
| 0.224 | 0.009 | 0.443 | Triose-phosphate isomerase inhibitor | 0.443 0.003 CID_22827811 | CID_22827811 | |
| 0.238 | 0.024 | 0.238 | Cyclooxygenase 1 inhibitor | 0.125 0.076 CID_22827811 | ||
| 0.22 | 0.005 | 0.22 | GABA C receptor rho-1 antagonist | |||
| 0.311 | 0.097 | 0.311 | Prostaglandin dehydrogenase inhibitor | |||
| 0.3 | 0.086 | 0.566 | Apoptosis antagonist | 0.566 0.013 CID_22827811 | CID_22827811 | |
| 0.215 | 0.004 | 0.215 | Estrogen receptor beta agonist | |||
| 0.221 | 0.011 | 0.221 | Carbonic anhydrase VI inhibitor | 0.093 0.044 CID_22827811 | ||
| 0.214 | 0.004 | 0.214 | Lanosterol 14 alpha demethylase inhibitor | 0.095 0.064 CID_22827811 | ||
| 0.23 | 0.02 | 0.425 | Cell wall synthesis inhibitor | 0.425 0.005 CID_22827811 | CID_22827811 | |
| 0.268 | 0.059 | 0.268 | Gastrin inhibitor | 0.231 0.103 CID_22827811 | ||
| 0.217 | 0.008 | 0.217 | Adenylate cyclase stimulant | 0.158 0.051 CID_22827811 | ||
| 0.298 | 0.089 | 0.722 | Antithrombotic | 0.722 0.007 CID_22827811 | CID_22827811 | |
| 0.247 | 0.039 | 0.247 | Dual specificity phosphatase inhibitor | |||
| 0.227 | 0.019 | 0.227 | 5-Lipoxygenase inhibitor | |||
| 0.215 | 0.008 | 0.215 | NMDA 2 receptor antagonist | |||
| 0.214 | 0.01 | 0.214 | Interleukin 8 antagonist | 0.1 0.096 CID_22827811 | ||
| 0.251 | 0.048 | 0.251 | Sigma receptor agonist | |||
| 0.212 | 0.011 | 0.212 | Alcohol dehydrogenase inhibitor | 0.149 0.021 CID_22827811 | ||
| 0.247 | 0.048 | 0.336 | DNA methyltransferase I inhibitor | 0.336 0.016 CID_22827811 | CID_22827811 | |
| 0.212 | 0.013 | 0.266 | Topoisomerase II alpha inhibitor | 0.266 0.009 CID_22827811 | CID_22827811 | |
| 0.198 | 0.004 | 0.198 | Ca2+-transporting ATPase inhibitor | 0.192 0.004 CID_22827811 | ||
| 0.198 | 0.007 | 0.207 | Heat shock protein 70 antagonist | 0.207 0.005 CID_22827811 | CID_22827811 | |
| 0.272 | 0.082 | 0.38 | Spasmolytic | 0.38 0.044 CID_22827811 | CID_22827811 | |
| 0.258 | 0.068 | 0.355 | Antiamyloidogenic | 0.355 0.038 CID_22827811 | CID_22827811 | |
| 0.224 | 0.034 | 0.224 | MAO inhibitor | |||
| 0.21 | 0.02 | 0.21 | Toll-Like receptor 2 antagonist | |||
| 0.2 | 0.01 | 0.2 | TRPA1 agonist | 0.131 0.047 CID_22827811 | ||
| 0.328 | 0.139 | 0.864 | Cyclophilin D inhibitor | 0.864 0.005 CID_22827811 | CID_22827811 | |
| 0.196 | 0.01 | 0.196 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.191 | 0.008 | 0.191 | Glutamate decarboxylase inhibitor | |||
| 0.195 | 0.012 | 0.195 | Pregnane X receptor agonist | |||
| 0.24 | 0.058 | 0.452 | Peptidyltransferase inhibitor | 0.452 0.004 CID_22827811 | CID_22827811 | |
| 0.196 | 0.014 | 0.202 | Carbonic anhydrase XIII inhibitor | 0.202 0.014 CID_22827811 | CID_22827811 | |
| 0.237 | 0.056 | 0.355 | DNA methylase inhibitor | 0.355 0.016 CID_22827811 | CID_22827811 | |
| 0.195 | 0.014 | 0.195 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.191 | 0.01 | 0.191 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.216 | 0.036 | 0.388 | Protein kinase stimulant | 0.388 0.009 CID_22827811 | CID_22827811 | |
| 0.183 | 0.004 | 0.183 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.237 | 0.06 | 0.237 | MAP kinase kinase 2 inhibitor | |||
| 0.181 | 0.004 | 0.181 | NMDA receptor subunit 3A antagonist | |||
| 0.277 | 0.101 | 0.277 | Sodium/bile acid cotransporter inhibitor | |||
| 0.31 | 0.134 | 0.31 | Analgesic | |||
| 0.211 | 0.037 | 0.358 | Lipid peroxidase inhibitor | 0.358 0.012 CID_22827811 | CID_22827811 | |
| 0.223 | 0.052 | 0.223 | Insulin sensitizer | 0.219 0.055 CID_22827811 | ||
| 0.202 | 0.033 | 0.202 | Death-associated protein kinase 2 inhibitor | |||
| 0.187 | 0.018 | 0.187 | Catalase inhibitor | |||
| 0.181 | 0.013 | 0.181 | Urease inhibitor | |||
| 0.195 | 0.027 | 0.195 | Glutamate receptor antagonist | |||
| 0.179 | 0.015 | 0.526 | AMP-activated protein kinase stimulant | 0.526 0.003 CID_22827811 | CID_22827811 | |
| 0.203 | 0.041 | 0.203 | Cyclooxygenase inhibitor | 0.123 0.096 CID_22827811 | ||
| 0.195 | 0.034 | 0.332 | Topoisomerase II inhibitor | 0.332 0.015 CID_22827811 | CID_22827811 | |
| 0.163 | 0.003 | 0.163 | Dopamine D5 agonist | |||
| 0.201 | 0.04 | 0.306 | Interleukin 6 antagonist | 0.306 0.014 CID_22827811 | CID_22827811 | |
| 0.243 | 0.084 | 0.273 | DNA damaging | 0.273 0.069 CID_22827811 | CID_22827811 | |
| 0.164 | 0.005 | 0.164 | Glycine receptor agonist | 0.142 0.008 CID_22827811 | ||
| 0.171 | 0.013 | 0.171 | Transcription factor STAT6 inhibitor | |||
| 0.173 | 0.014 | 0.173 | Prolactin inhibitor | |||
| 0.171 | 0.013 | 0.171 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.164 | 0.006 | 0.164 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.252 | 0.095 | 0.534 | Immunostimulant | 0.534 0.025 CID_22827811 | CID_22827811 | |
| 0.184 | 0.028 | 0.184 | MAO B inhibitor | |||
| 0.18 | 0.024 | 0.273 | Xanthine oxidase inhibitor | 0.273 0.01 CID_22827811 | CID_22827811 | |
| 0.165 | 0.01 | 0.165 | Histamine N-methyltransferase inhibitor | |||
| 0.174 | 0.019 | 0.174 | Adenylate kinase inhibitor | 0.141 0.03 CID_22827811 | ||
| 0.159 | 0.006 | 0.159 | NMDA 2A receptor antagonist | |||
| 0.185 | 0.032 | 0.185 | MAO A inhibitor | |||
| 0.188 | 0.036 | 0.405 | Monophenol monooxygenase inhibitor | 0.405 0.011 CID_22827811 | CID_22827811 | |
| 0.166 | 0.015 | 0.29 | Phosphofructokinase-1 inhibitor | 0.29 0.006 CID_22827811 | CID_22827811 | |
| 0.18 | 0.029 | 0.18 | Cathepsin H inhibitor | |||
| 0.2 | 0.049 | 0.2 | Antipruritic | |||
| 0.158 | 0.008 | 0.158 | NMDA 2B receptor antagonist | |||
| 0.196 | 0.046 | 0.423 | Diuretic | 0.423 0.012 CID_22827811 | CID_22827811 | |
| 0.179 | 0.03 | 0.179 | Neuropeptide Y1 antagonist | |||
| 0.231 | 0.083 | 0.231 | Calpain inhibitor | |||
| 0.161 | 0.013 | 0.161 | Anabolic | 0.1 0.062 CID_22827811 | ||
| 0.166 | 0.018 | 0.166 | Sphingomyelinase inhibitor | 0.154 0.023 CID_22827811 | ||
| 0.155 | 0.007 | 0.155 | NMDA receptor agonist | |||
| 0.333 | 0.186 | 0.83 | Antiinflammatory | 0.83 0.012 CID_22827811 | CID_22827811 | |
| 0.153 | 0.007 | 0.153 | Purinergic P2X1 antagonist | 0.086 0.022 CID_22827811 | ||
| 0.148 | 0.004 | 0.148 | Estrogen-related receptor beta agonist | |||
| 0.16 | 0.018 | 0.16 | Protein kinase C zeta inhibitor | |||
| 0.153 | 0.011 | 0.153 | Estrogen receptor alpha antagonist | |||
| 0.158 | 0.017 | 0.201 | Toll-Like receptor 4 antagonist | 0.201 0.006 CID_22827811 | CID_22827811 | |
| 0.172 | 0.033 | 0.172 | Adenylate cyclase inhibitor | 0.111 0.075 CID_22827811 | ||
| 0.147 | 0.008 | 0.207 | Glycine receptor antagonist | 0.207 0.003 CID_22827811 | CID_22827811 | |
| 0.168 | 0.031 | 0.168 | Aminopeptidase B inhibitor | |||
| 0.186 | 0.05 | 0.186 | Phospholipase A2 inhibitor | 0.157 0.068 CID_22827811 | ||
| 0.273 | 0.137 | 0.402 | Antiobesity | 0.402 0.065 CID_22827811 | CID_22827811 | |
| 0.139 | 0.004 | 0.139 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.254 | 0.121 | 0.254 | Thyroid hormone antagonist | |||
| 0.138 | 0.005 | 0.138 | NMDA receptor glycine site agonist | |||
| 0.143 | 0.011 | 0.143 | Bromodomain-containing protein 2 inhibitor | |||
| 0.2 | 0.069 | 0.2 | Histone acetyltransferase inhibitor | |||
| 0.142 | 0.012 | 0.142 | Carbamoyl phosphate synthetase inhibitor | 0.085 0.026 CID_22827811 | ||
| 0.145 | 0.017 | 0.145 | Glutamate dehydrogenase inhibitor | 0.102 0.03 CID_22827811 | ||
| 0.135 | 0.008 | 0.135 | NMDA 2C receptor antagonist | |||
| 0.136 | 0.009 | 0.136 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.134 0.009 CID_22827811 | ||
| 0.141 | 0.014 | 0.141 | Glutathione S-transferase inhibitor | 0.083 0.056 CID_22827811 | ||
| 0.165 | 0.038 | 0.165 | MAP kinase kinase 4 inhibitor | |||
| 0.145 | 0.018 | 0.145 | MAP kinase kinase 1 inhibitor | |||
| 0.142 | 0.016 | 0.142 | Dopamine D1 antagonist | |||
| 0.143 | 0.017 | 0.143 | Adrenaline agonist | |||
| 0.168 | 0.042 | 0.168 | MAP kinase kinase inhibitor | |||
| 0.129 | 0.003 | 0.129 | ATP citrate lysase inhibitor | 0.033 0.02 CID_22827811 | ||
| 0.131 | 0.006 | 0.131 | Aryl hydrocarbon receptor antagonist | |||
| 0.13 | 0.005 | 0.13 | Heat shock protein 90 beta antagonist | |||
| 0.291 | 0.166 | 0.291 | DNA directed DNA polymerase inhibitor | |||
| 0.149 | 0.024 | 0.171 | CC chemokine 6 receptor antagonist | 0.171 0.008 CID_22827811 | CID_22827811 | |
| 0.139 | 0.014 | 0.139 | Interleukin 5 antagonist | 0.114 0.028 CID_22827811 | ||
| 0.157 | 0.032 | 0.157 | Vanilloid 1 agonist | 0.144 0.045 CID_22827811 | ||
| 0.138 | 0.014 | 0.138 | Myeloperoxidase inhibitor | |||
| 0.135 | 0.011 | 0.135 | Bile acid receptor antagonist | 0.099 0.052 CID_22827811 | ||
| 0.159 | 0.039 | 0.159 | Antibacterial (Helicobacter pylori) | |||
| 0.153 | 0.034 | 0.153 | Chelator | |||
| 0.136 | 0.018 | 0.136 | Carbonic anhydrase V inhibitor | |||
| 0.168 | 0.05 | 0.494 | Hemostatic | 0.494 0.004 CID_22827811 | CID_22827811 | |
| 0.134 | 0.018 | 0.134 | Keratolytic | |||
| 0.127 | 0.013 | 0.127 | HIV-1 integrase inhibitor | |||
| 0.148 | 0.034 | 0.158 | Mucolytic | 0.158 0.028 CID_22827811 | CID_22827811 | |
| 0.147 | 0.033 | 0.217 | Photosensitizer | 0.217 0.01 CID_22827811 | CID_22827811 | |
| 0.164 | 0.05 | 0.164 | Nav1.2 sodium channel blocker | |||
| 0.125 | 0.012 | 0.125 | Carbonic anhydrase VB inhibitor | |||
| 0.239 | 0.125 | 0.239 | Thyroid hormone beta antagonist | |||
| 0.119 | 0.006 | 0.119 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.139 | 0.026 | 0.139 | Androgen antagonist | |||
| 0.12 | 0.007 | 0.12 | Vanilloid 4 agonist | |||
| 0.118 | 0.005 | 0.118 | Exportin-1 inhibitor | |||
| 0.136 | 0.025 | 0.136 | Potassium channel activator | |||
| 0.172 | 0.061 | 0.172 | Protein-tyrosine phosphatase inhibitor | 0.166 0.065 CID_22827811 | ||
| 0.162 | 0.051 | 0.162 | MAP kinase 3 inhibitor | |||
| 0.156 | 0.046 | 0.18 | DNA polymerase I inhibitor | 0.18 0.035 CID_22827811 | CID_22827811 | |
| 0.128 | 0.017 | 0.128 | Prostaglandin-E synthase inhibitor | |||
| 0.179 | 0.068 | 0.179 | Tumour necrosis factor antagonist | |||
| 0.132 | 0.022 | 0.132 | CYP2A6 inhibitor | |||
| 0.157 | 0.047 | 0.157 | Nav1.6 sodium channel blocker | |||
| 0.141 | 0.031 | 0.141 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.118 | 0.009 | 0.118 | CC chemokine 5 receptor agonist | |||
| 0.127 | 0.018 | 0.127 | HIV-1 integrase (3'-Processing) inhibitor | 0.061 0.046 CID_22827811 | ||
| 0.11 | 0.003 | 0.11 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.04 0.033 CID_22827811 | ||
| 0.182 | 0.075 | 0.494 | Nitric oxide antagonist | 0.494 0.016 CID_22827811 | CID_22827811 | |
| 0.112 | 0.006 | 0.112 | MAP kinase kinase 7 inhibitor | |||
| 0.169 | 0.063 | 0.169 | Cytidine deaminase inhibitor | |||
| 0.136 | 0.029 | 0.19 | Uric acid excretion stimulant | 0.19 0.014 CID_22827811 | CID_22827811 | |
| 0.111 | 0.004 | 0.111 | Dihydroorotate oxidase inhibitor | |||
| 0.126 | 0.019 | 0.126 | Cyclin B3 inhibitor | |||
| 0.121 | 0.015 | 0.121 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.165 | 0.06 | 0.408 | Insulin secretagoues | 0.408 0.006 CID_22827811 | CID_22827811 | |
| 0.116 | 0.011 | 0.116 | Beta 3 adrenoreceptor antagonist | |||
| 0.109 | 0.005 | 0.109 | MDM2 inhibitor | |||
| 0.144 | 0.04 | 0.144 | Falcipain 3 inhibitor | |||
| 0.112 | 0.009 | 0.112 | Phospholipase D inhibitor | |||
| 0.112 | 0.009 | 0.112 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.121 | 0.018 | 0.121 | Carbonic anhydrase VA inhibitor | |||
| 0.14 | 0.038 | 0.14 | Protein kinase C gamma inhibitor | |||
| 0.108 | 0.006 | 0.108 | Sphingosine kinase 2 inhibitor | |||
| 0.11 | 0.008 | 0.11 | Glutamate (mGluR6) antagonist | 0.075 0.03 CID_22827811 | ||
| 0.116 | 0.015 | 0.133 | Aldose reductase inhibitor | 0.133 0.012 CID_22827811 | CID_22827811 | |
| 0.105 | 0.005 | 0.105 | Calcium channel P-type blocker | |||
| 0.141 | 0.04 | 0.272 | DNA repair enzyme inhibitor | 0.272 0.005 CID_22827811 | CID_22827811 | |
| 0.152 | 0.052 | 0.152 | Cyclooxygenase 2 inhibitor | |||
| 0.104 | 0.005 | 0.104 | Purinergic P2X4 antagonist | |||
| 0.195 | 0.096 | 0.195 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.11 | 0.012 | 0.26 | Phosphorylase inhibitor | 0.26 0.004 CID_22827811 | CID_22827811 | |
| 0.102 | 0.004 | 0.102 | Adenylate cyclase 1 inhibitor | |||
| 0.131 | 0.033 | 0.139 | Acetylcholine release stimulant | 0.139 0.024 CID_22827811 | CID_22827811 | |
| 0.141 | 0.043 | 0.192 | Microtubule formation inhibitor | 0.192 0.022 CID_22827811 | CID_22827811 | |
| 0.109 | 0.012 | 0.109 | 5 Hydroxytryptamine 2A agonist | |||
| 0.116 | 0.018 | 0.116 | Leukotriene synthesis inhibitor | |||
| 0.125 | 0.028 | 0.16 | Thioredoxin inhibitor | 0.16 0.014 CID_22827811 | CID_22827811 | |
| 0.114 | 0.019 | 0.114 | Aromatase inhibitor | |||
| 0.11 | 0.016 | 0.11 | Biliverdin reductase inhibitor | 0.075 0.029 CID_22827811 | ||
| 0.107 | 0.012 | 0.107 | Androgen agonist | |||
| 0.118 | 0.025 | 0.118 | Opioid kappa receptor antagonist | |||
| 0.097 | 0.004 | 0.097 | Pregnane X receptor antagonist | |||
| 0.126 | 0.034 | 0.126 | Opioid antagonist | |||
| 0.105 | 0.013 | 0.105 | 5 Hydroxytryptamine 3 agonist | |||
| 0.132 | 0.041 | 0.132 | Protein kinase (CK2) inhibitor | |||
| 0.118 | 0.028 | 0.118 | Cathepsin G inhibitor | |||
| 0.098 | 0.01 | 0.098 | Botulinum neurotoxin type A inhibitor | |||
| 0.111 | 0.023 | 0.111 | Aminopeptidase I inhibitor | |||
| 0.107 | 0.02 | 0.107 | HIV-1 integrase (Strand Transfer) inhibitor | 0.057 0.044 CID_22827811 | ||
| 0.156 | 0.069 | 0.156 | Acetylcholine M1 receptor antagonist | |||
| 0.104 | 0.017 | 0.104 | TRPA1 antagonist | |||
| 0.092 | 0.004 | 0.092 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.11 | 0.023 | 0.11 | Dopamine agonist | |||
| 0.131 | 0.045 | 0.131 | Caspase 3 inhibitor | |||
| 0.089 | 0.003 | 0.089 | Estrogen-related receptor beta antagonist | |||
| 0.09 | 0.004 | 0.09 | Dopamine beta hydroxylase inhibitor | |||
| 0.097 | 0.012 | 0.097 | Glutamate (mGluR7) antagonist | |||
| 0.267 | 0.182 | 0.267 | DNA polymerase beta inhibitor | |||
| 0.1 | 0.015 | 0.1 | Cannabinoid CB2 receptor antagonist | |||
| 0.117 | 0.032 | 0.138 | Interleukin 12 antagonist | 0.138 0.017 CID_22827811 | CID_22827811 | |
| 0.108 | 0.024 | 0.108 | CDC25A inhibitor | |||
| 0.103 | 0.02 | 0.103 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.117 | 0.034 | 0.117 | Glutamate (mGluR7) agonist | |||
| 0.146 | 0.063 | 0.146 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.104 | 0.022 | 0.104 | Amidase inhibitor | |||
| 0.099 | 0.017 | 0.099 | Cannabinoid CB1 receptor antagonist | |||
| 0.088 | 0.006 | 0.093 | Adenine nucleotide translocase inhibitor | 0.093 0.005 CID_22827811 | CID_22827811 | |
| 0.086 | 0.005 | 0.086 | Glutamate (mGluR3) antagonist | |||
| 0.107 | 0.026 | 0.107 | Cannabinoid receptor antagonist | |||
| 0.096 | 0.015 | 0.113 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.113 0.012 CID_22827811 | CID_22827811 | |
| 0.091 | 0.01 | 0.091 | Aconitate hydratase inhibitor | |||
| 0.087 | 0.006 | 0.087 | Potassium channel (Inward rectifier) activator | |||
| 0.097 | 0.017 | 0.097 | Acyl-CoA dehydrogenase inhibitor | 0.051 0.041 CID_22827811 | ||
| 0.229 | 0.149 | 0.229 | Thioredoxin glutathione reductase inhibitor | |||
| 0.086 | 0.007 | 0.131 | Glucose-6-phosphate isomerase inhibitor | 0.131 0.003 CID_22827811 | CID_22827811 | |
| 0.086 | 0.007 | 0.086 | CXC chemokine 1 receptor antagonist | |||
| 0.116 | 0.038 | 0.116 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.185 | 0.107 | 0.185 | Dyrk kinase inhibitor | |||
| 0.084 | 0.006 | 0.084 | Potassium channel (ATP-sensitive) activator | |||
| 0.106 | 0.029 | 0.106 | Opioid delta receptor antagonist | |||
| 0.132 | 0.054 | 0.132 | Protein kinase (CK2) alpha inhibitor | |||
| 0.088 | 0.011 | 0.088 | Topoisomerase II beta inhibitor | 0.06 0.022 CID_22827811 | ||
| 0.135 | 0.059 | 0.135 | Nav1.3 sodium channel blocker | |||
| 0.09 | 0.014 | 0.09 | Fatty acid synthase inhibitor | |||
| 0.118 | 0.043 | 0.159 | Falcipain 2 inhibitor | 0.159 0.025 CID_22827811 | CID_22827811 | |
| 0.103 | 0.029 | 0.124 | Na+ K+ transporting ATPase inhibitor | 0.124 0.014 CID_22827811 | CID_22827811 | |
| 0.097 | 0.023 | 0.097 | Beta tubulin antagonist | |||
| 0.091 | 0.017 | 0.091 | Alpha tubulin antagonist | |||
| 0.119 | 0.045 | 0.162 | Falcipain inhibitor | 0.162 0.026 CID_22827811 | CID_22827811 | |
| 0.103 | 0.029 | 0.103 | mTOR complex 2 inhibitor | |||
| 0.256 | 0.182 | 0.256 | Transcription factor inhibitor | |||
| 0.124 | 0.05 | 0.124 | Nav1.5 sodium channel blocker | |||
| 0.092 | 0.018 | 0.092 | Xanthine dehydrogenase inhibitor | |||
| 0.077 | 0.004 | 0.077 | Protein kinase (CK2) beta inhibitor | |||
| 0.12 | 0.047 | 0.307 | Mediator release inhibitor | 0.307 0.007 CID_22827811 | CID_22827811 | |
| 0.122 | 0.049 | 0.365 | Expectorant | 0.365 0.005 CID_22827811 | CID_22827811 | |
| 0.079 | 0.006 | 0.079 | GABA B receptor antagonist | |||
| 0.084 | 0.011 | 0.084 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.076 | 0.003 | 0.076 | CF transmembrane conductance regulator antagonist | |||
| 0.16 | 0.089 | 0.16 | LIM domain kinase 1 inhibitor | |||
| 0.081 | 0.011 | 0.131 | Glucose-6-phosphate translocase inhibitor | 0.131 0.004 CID_22827811 | CID_22827811 | |
| 0.08 | 0.01 | 0.08 | Squalene epoxidase inhibitor | |||
| 0.076 | 0.005 | 0.076 | Alpha 1d adrenoreceptor agonist | |||
| 0.145 | 0.074 | 0.145 | Thiol protease inhibitor | |||
| 0.138 | 0.069 | 0.138 | Bone formation stimulant | 0.109 0.097 CID_22827811 | ||
| 0.09 | 0.022 | 0.09 | Argininosuccinate synthase inhibitor | 0.063 0.035 CID_22827811 | ||
| 0.081 | 0.012 | 0.081 | 5 Hydroxytryptamine 7 agonist | |||
| 0.103 | 0.034 | 0.103 | Inducible nitric-oxide synthase inhibitor | |||
| 0.089 | 0.021 | 0.089 | CDC25B inhibitor | |||
| 0.164 | 0.096 | 0.562 | Hepatoprotectant | 0.562 0.005 CID_22827811 | CID_22827811 | |
| 0.083 | 0.015 | 0.083 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.078 | 0.01 | 0.078 | Beta 2 adrenoreceptor agonist | |||
| 0.076 | 0.009 | 0.076 | Phosphoglycerate kinase inhibitor | 0.035 0.024 CID_22827811 | ||
| 0.071 | 0.004 | 0.158 | Sodium/glucose cotransporter 2 inhibitor | 0.158 0.001 CID_22827811 | CID_22827811 | |
| 0.081 | 0.015 | 0.081 | Sphingosine kinase inhibitor | |||
| 0.12 | 0.055 | 0.12 | CDK3/cyclin E inhibitor | |||
| 0.089 | 0.023 | 0.089 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.121 | 0.055 | 0.284 | Topoisomerase I inhibitor | 0.284 0.012 CID_22827811 | CID_22827811 | |
| 0.098 | 0.033 | 0.098 | Opioid mu receptor antagonist | |||
| 0.073 | 0.008 | 0.073 | Liver X receptor alpha agonist | |||
| 0.121 | 0.056 | 0.121 | GABA receptor agonist | |||
| 0.069 | 0.004 | 0.069 | Heme oxygenase inhibitor | |||
| 0.078 | 0.014 | 0.078 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.067 | 0.004 | 0.067 | CXC chemokine 2 receptor antagonist | |||
| 0.08 | 0.017 | 0.08 | Transcription factor RelA inhibitor | |||
| 0.076 | 0.014 | 0.076 | Carbonic anhydrase VII inhibitor | |||
| 0.079 | 0.017 | 0.116 | Carbonic anhydrase XIV inhibitor | 0.116 0.008 CID_22827811 | CID_22827811 | |
| 0.085 | 0.024 | 0.085 | Beta adrenoreceptor antagonist | |||
| 0.081 | 0.02 | 0.081 | Thromboxane antagonist | |||
| 0.103 | 0.042 | 0.103 | Aminoacyl-tRNA synthetase inhibitor | 0.08 0.077 CID_22827811 | ||
| 0.165 | 0.104 | 0.165 | I kappa B kinase epsilon inhibitor | |||
| 0.071 | 0.01 | 0.071 | CC chemokine 4 receptor antagonist | |||
| 0.084 | 0.024 | 0.084 | Dopamine uptake inhibitor | |||
| 0.097 | 0.037 | 0.097 | Vanilloid agonist | |||
| 0.145 | 0.085 | 0.145 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.066 | 0.006 | 0.066 | Nerve growth factor antagonist | |||
| 0.095 | 0.035 | 0.095 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.104 | 0.044 | 0.15 | Phosphodiesterase 6D inhibitor | 0.15 0.01 CID_22827811 | CID_22827811 | |
| 0.065 | 0.005 | 0.065 | Kainate receptor agonist | |||
| 0.074 | 0.014 | 0.074 | Glutamate (mGluR group III) agonist | |||
| 0.126 | 0.067 | 0.126 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.079 | 0.02 | 0.079 | Prostaglandin E2 antagonist | |||
| 0.071 | 0.012 | 0.071 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.068 | 0.009 | 0.068 | Nicotinic acid receptor agonist | |||
| 0.078 | 0.019 | 0.078 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.078 | 0.02 | 0.078 | Cyclin D1 inhibitor | |||
| 0.094 | 0.035 | 0.094 | Thioredoxin reductase inhibitor | |||
| 0.063 | 0.005 | 0.063 | Liver X receptor beta antagonist | |||
| 0.072 | 0.014 | 0.072 | CD45 antagonist | |||
| 0.083 | 0.025 | 0.083 | Potassium channel (ATP-sensitive) blocker | |||
| 0.117 | 0.06 | 0.117 | Alpha 2b adrenoreceptor antagonist | |||
| 0.085 | 0.028 | 0.085 | Bcl2 antagonist | |||
| 0.066 | 0.009 | 0.066 | Dihydropteroate synthase inhibitor | |||
| 0.061 | 0.005 | 0.061 | NMDA receptor glycine site antagonist | |||
| 0.076 | 0.021 | 0.076 | Beta 1 adrenoreceptor antagonist | |||
| 0.091 | 0.036 | 0.091 | Analgesic, opioid | |||
| 0.072 | 0.017 | 0.072 | Epithelial sodium channel blocker | |||
| 0.074 | 0.019 | 0.074 | Glucosylceramidase inhibitor | 0.05 0.049 CID_22827811 | ||
| 0.13 | 0.076 | 0.13 | Interleukin 1 antagonist | |||
| 0.059 | 0.005 | 0.059 | Kynurenine 3 monooxygenase inhibitor | 0.027 0.018 CID_22827811 | ||
| 0.074 | 0.02 | 0.074 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.121 | 0.067 | 0.144 | Beta amyloid protein antagonist | 0.144 0.045 CID_22827811 | CID_22827811 | |
| 0.076 | 0.023 | 0.076 | Phosphodiesterase 1C inhibitor | |||
| 0.067 | 0.014 | 0.067 | Immunoglobulin Fc receptor antagonist | |||
| 0.138 | 0.085 | 0.138 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | |||
| 0.073 | 0.019 | 0.073 | Thromboxane A2 antagonist | |||
| 0.074 | 0.022 | 0.074 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.07 | 0.017 | 0.188 | Alpha-mannosidase inhibitor | 0.188 0.003 CID_22827811 | CID_22827811 | |
| 0.078 | 0.025 | 0.078 | Alpha 2 adrenoreceptor agonist | |||
| 0.062 | 0.01 | 0.062 | Fumarate hydratase inhibitor | 0.046 0.015 CID_22827811 | ||
| 0.076 | 0.023 | 0.076 | GABA receptor antagonist | |||
| 0.06 | 0.009 | 0.06 | p53 inhibitor | |||
| 0.057 | 0.005 | 0.057 | Vanilloid 3 antagonist | |||
| 0.058 | 0.008 | 0.058 | Glutamate (mGluR8) agonist | |||
| 0.164 | 0.114 | 0.836 | Angiogenesis stimulant | 0.836 0.003 CID_22827811 | CID_22827811 | |
| 0.069 | 0.019 | 0.069 | Ryanodine receptor antagonist | |||
| 0.055 | 0.005 | 0.195 | Sodium/glucose cotransporter inhibitor | 0.195 0.001 CID_22827811 | CID_22827811 | |
| 0.067 | 0.017 | 0.067 | Leukotriene C antagonist | |||
| 0.064 | 0.014 | 0.064 | Cholesterol esterase inhibitor | |||
| 0.054 | 0.005 | 0.054 | Ceramide glucosyltransferase inhibitor | 0.054 0.005 CID_22827811 | ||
| 0.064 | 0.014 | 0.064 | Oxytocin agonist | |||
| 0.097 | 0.048 | 0.097 | Ornithine decarboxylase inhibitor | |||
| 0.058 | 0.009 | 0.058 | 5 Hydroxytryptamine 2B agonist | |||
| 0.063 | 0.015 | 0.063 | Carnitine palmitoyltransferase 1B inhibitor | |||
| 0.085 | 0.038 | 0.085 | Lipase inhibitor | |||
| 0.057 | 0.01 | 0.057 | Alpha 1L adrenoreceptor agonist | |||
| 0.068 | 0.021 | 0.068 | 5 Hydroxytryptamine 2 agonist | |||
| 0.066 | 0.019 | 0.066 | Beta 2 adrenoreceptor antagonist | |||
| 0.072 | 0.025 | 0.072 | Kallikrein 7 inhibitor | |||
| 0.159 | 0.112 | 0.159 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.062 | 0.015 | 0.062 | Kainate receptor antagonist | |||
| 0.117 | 0.071 | 0.23 | Alkylator | 0.23 0.019 CID_22827811 | CID_22827811 | |
| 0.089 | 0.043 | 0.089 | Caspase 7 inhibitor | |||
| 0.071 | 0.025 | 0.071 | GABA A receptor antagonist | |||
| 0.057 | 0.012 | 0.057 | Estrogen-related receptor alpha antagonist | |||
| 0.052 | 0.007 | 0.052 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.053 | 0.008 | 0.053 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.046 0.009 CID_22827811 | ||
| 0.05 | 0.004 | 0.05 | Thyroid hormone agonist | |||
| 0.056 | 0.011 | 0.056 | Sirtuin 2 inhibitor | |||
| 0.052 | 0.007 | 0.067 | Uridine phosphorylase inhibitor | 0.067 0.004 CID_22827811 | CID_22827811 | |
| 0.049 | 0.004 | 0.049 | Alpha 2a adrenoreceptor agonist | |||
| 0.115 | 0.071 | 0.115 | Anesthetic local | |||
| 0.078 | 0.034 | 0.078 | Protein kinase C beta inhibitor | |||
| 0.048 | 0.004 | 0.048 | Estrogen-related receptor gamma antagonist | |||
| 0.083 | 0.039 | 0.083 | Adenosine A3 receptor antagonist | |||
| 0.056 | 0.012 | 0.056 | Farnesoid X receptor agonist | |||
| 0.108 | 0.065 | 0.108 | Nav1.4 sodium channel blocker | |||
| 0.063 | 0.019 | 0.262 | Heparanase inhibitor | 0.262 0.002 CID_22827811 | CID_22827811 | |
| 0.055 | 0.012 | 0.055 | AMPA 4 receptor antagonist | |||
| 0.073 | 0.029 | 0.073 | Prostaglandin F2 alpha antagonist | |||
| 0.087 | 0.044 | 0.127 | T cell inhibitor | 0.127 0.013 CID_22827811 | CID_22827811 | |
| 0.055 | 0.012 | 0.055 | Beta adrenoreceptor agonist | |||
| 0.052 | 0.01 | 0.052 | Liver X receptor beta agonist | |||
| 0.048 | 0.005 | 0.048 | Glutamate (mGluR3) agonist | |||
| 0.123 | 0.081 | 0.123 | Sodium channel (voltage-gated) blocker | |||
| 0.077 | 0.034 | 0.077 | Leukotriene antagonist | 0.072 0.038 CID_22827811 | ||
| 0.052 | 0.009 | 0.052 | Glucagon receptor antagonist | |||
| 0.057 | 0.014 | 0.065 | Guanylate cyclase inhibitor | 0.065 0.007 CID_22827811 | CID_22827811 | |
| 0.055 | 0.013 | 0.055 | GABA uptake inhibitor | |||
| 0.057 | 0.015 | 0.057 | Glutamate (mGluR4) antagonist | |||
| 0.061 | 0.02 | 0.061 | Potassium channel Kv1.3 blocker | |||
| 0.056 | 0.015 | 0.056 | Urate transporter 1 inhibitor | |||
| 0.064 | 0.023 | 0.064 | Glycine transporter 2 inhibitor | |||
| 0.09 | 0.049 | 0.09 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | |||
| 0.052 | 0.012 | 0.052 | RNA-directed RNA polymerase inhibitor | |||
| 0.049 | 0.009 | 0.049 | Catechol O-methyltransferase inhibitor | |||
| 0.058 | 0.018 | 0.192 | Mannosidase inhibitor | 0.192 0.003 CID_22827811 | CID_22827811 | |
| 0.056 | 0.017 | 0.056 | Geranyltranstransferase inhibitor | |||
| 0.056 | 0.017 | 0.056 | Benzodiazepine antagonist | |||
| 0.077 | 0.038 | 0.077 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.043 | 0.005 | 0.043 | Prostaglandin F2 alpha agonist | 0.021 0.018 CID_22827811 | ||
| 0.077 | 0.04 | 0.077 | Alpha adrenoreceptor agonist | |||
| 0.091 | 0.054 | 0.141 | ATPase (Vacuolar H+) inhibitor | 0.141 0.01 CID_22827811 | CID_22827811 | |
| 0.078 | 0.04 | 0.078 | Potassium channel (Tandem pore domain) blocker | |||
| 0.041 | 0.003 | 0.041 | Nicotinic acid receptor 1 antagonist | |||
| 0.043 | 0.005 | 0.043 | Purinergic P2Y15 antagonist | |||
| 0.062 | 0.025 | 0.062 | Thromboxane synthase inhibitor | |||
| 0.05 | 0.013 | 0.05 | Potassium channel Kv1.1 blocker | |||
| 0.095 | 0.058 | 0.095 | ABCA1 expression enhancer | |||
| 0.049 | 0.012 | 0.049 | Delayed rectifier potassium channel blocker | |||
| 0.045 | 0.009 | 0.045 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.056 | 0.02 | 0.056 | Opioid kappa receptor agonist | |||
| 0.04 | 0.004 | 0.04 | Hedgehog signaling activator | |||
| 0.047 | 0.012 | 0.047 | Glutamate (mGluR4) agonist | |||
| 0.052 | 0.018 | 0.052 | Thymidine kinase inhibitor | |||
| 0.053 | 0.018 | 0.053 | Glutamate (mGluR group III) antagonist | |||
| 0.05 | 0.016 | 0.05 | Kainate receptor 2 antagonist | |||
| 0.047 | 0.013 | 0.047 | Integrin alpha2 antagonist | |||
| 0.054 | 0.02 | 0.054 | Dihydroorotase inhibitor | |||
| 0.049 | 0.016 | 0.085 | Arginase inhibitor | 0.085 0.005 CID_22827811 | CID_22827811 | |
| 0.045 | 0.012 | 0.045 | HCV NS5B polymerase inhibitor | |||
| 0.109 | 0.076 | 0.109 | Proteasome inhibitor | |||
| 0.056 | 0.023 | 0.056 | Dopamine D2 agonist | |||
| 0.044 | 0.011 | 0.044 | Carnitine palmitoyltransferase 1 inhibitor | |||
| 0.045 | 0.013 | 0.045 | Potassium channel small-conductance Ca-activated activator | |||
| 0.041 | 0.009 | 0.041 | CC chemokine 1 receptor antagonist | |||
| 0.044 | 0.012 | 0.044 | Carnitine palmitoyltransferase inhibitor | |||
| 0.053 | 0.02 | 0.053 | Erythropoietin receptor agonist | |||
| 0.044 | 0.012 | 0.044 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | |||
| 0.072 | 0.041 | 0.072 | Acetylcholine M5 receptor agonist | |||
| 0.054 | 0.023 | 0.054 | Dopamine D5 antagonist | |||
| 0.04 | 0.009 | 0.04 | Liver X receptor alpha antagonist | |||
| 0.039 | 0.009 | 0.039 | LFA antagonist | |||
| 0.037 | 0.007 | 0.037 | Thymidine phosphorylase inhibitor | |||
| 0.089 | 0.06 | 0.089 | Phosphodiesterase I inhibitor | |||
| 0.067 | 0.037 | 0.067 | Adrenaline uptake inhibitor | |||
| 0.056 | 0.027 | 0.056 | Bombesin 2 receptor antagonist | |||
| 0.074 | 0.045 | 0.074 | Benzodiazepine agonist | |||
| 0.035 | 0.007 | 0.035 | Nicotinic acid receptor 2 antagonist | |||
| 0.044 | 0.016 | 0.044 | Leukotriene C4 antagonist | |||
| 0.117 | 0.089 | 0.117 | Toll-Like receptor antagonist | |||
| 0.047 | 0.02 | 0.047 | Sphingosine kinase 1 inhibitor | |||
| 0.041 | 0.014 | 0.041 | AMPA 1 receptor antagonist | |||
| 0.041 | 0.015 | 0.041 | Free fatty acid receptor 1 antagonist | |||
| 0.035 | 0.008 | 0.035 | Integrin alpha2beta1 antagonist | |||
| 0.072 | 0.046 | 0.072 | Secretase beta inhibitor | |||
| 0.04 | 0.014 | 0.04 | Liver X receptor antagonist | |||
| 0.054 | 0.028 | 0.054 | AMPA receptor antagonist | |||
| 0.032 | 0.006 | 0.032 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.06 | 0.034 | 0.06 | Maillard reaction inhibitor | |||
| 0.046 | 0.02 | 0.046 | Progesterone antagonist | |||
| 0.095 | 0.069 | 0.095 | Nitric-oxide synthase inhibitor | |||
| 0.035 | 0.009 | 0.035 | Prostaglandin H2 antagonist | |||
| 0.039 | 0.013 | 0.039 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.067 | 0.041 | 0.067 | Carbonic anhydrase inhibitor | 0.063 0.044 CID_22827811 | ||
| 0.057 | 0.032 | 0.057 | Lysine-specific demethylase 1A inhibitor | |||
| 0.059 | 0.033 | 0.115 | Carbonic anhydrase XII inhibitor | 0.115 0.017 CID_22827811 | CID_22827811 | |
| 0.036 | 0.011 | 0.036 | Dopamine autoreceptor agonist | |||
| 0.033 | 0.008 | 0.033 | Glutamate (mGluR1a) agonist | |||
| 0.092 | 0.067 | 0.092 | DNA directed RNA polymerase inhibitor | |||
| 0.058 | 0.033 | 0.058 | Ornithine carbamoyltransferase inhibitor | |||
| 0.048 | 0.024 | 0.048 | AICAR transformylase inhibitor | |||
| 0.063 | 0.038 | 0.063 | Phosphodiesterase 1B inhibitor | |||
| 0.047 | 0.023 | 0.047 | Dihydrofolate reductase inhibitor | |||
| 0.051 | 0.027 | 0.051 | Thymidylate synthase inhibitor | |||
| 0.032 | 0.008 | 0.051 | Vanilloid 2 agonist | 0.051 0.003 CID_22827811 | CID_22827811 | |
| 0.052 | 0.029 | 0.052 | Adenosine deaminase inhibitor | 0.047 0.033 CID_22827811 | ||
| 0.046 | 0.024 | 0.046 | CDK5/p25 inhibitor | |||
| 0.027 | 0.004 | 0.027 | Thromboxane A2 agonist | |||
| 0.03 | 0.007 | 0.03 | ICAM 1 antagonist | |||
| 0.038 | 0.015 | 0.038 | Prostaglandin agonist | |||
| 0.21 | 0.187 | 0.548 | Immunosuppressant | 0.548 0.021 CID_22827811 | CID_22827811 | |
| 0.037 | 0.014 | 0.037 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.037 | 0.015 | 0.037 | AMPA 3 receptor antagonist | |||
| 0.062 | 0.04 | 0.062 | Acetylcholine M5 receptor antagonist | |||
| 0.106 | 0.084 | 0.106 | Acetylcholine muscarinic antagonist | |||
| 0.059 | 0.037 | 0.079 | Carbonic anhydrase IX inhibitor | 0.079 0.027 CID_22827811 | CID_22827811 | |
| 0.027 | 0.005 | 0.027 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.048 | 0.026 | 0.048 | Carbonic anhydrase IV inhibitor | |||
| 0.062 | 0.041 | 0.062 | Dopamine D4 antagonist | |||
| 0.042 | 0.02 | 0.042 | VCAM-1 antagonist | |||
| 0.035 | 0.014 | 0.035 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.042 | 0.02 | 0.042 | VCAM antagonist | |||
| 0.053 | 0.031 | 0.053 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.028 | 0.007 | 0.028 | Isoleucine-tRNA ligase inhibitor | 0.027 0.008 CID_22827811 | ||
| 0.029 | 0.009 | 0.029 | Beta 1 adrenoreceptor agonist | |||
| 0.031 | 0.01 | 0.031 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.062 | 0.043 | 0.062 | I kappa B kinase 2 inhibitor | |||
| 0.025 | 0.005 | 0.025 | Estrogen-related receptor gamma agonist | |||
| 0.051 | 0.032 | 0.051 | Bromodomain-containing protein 3 inhibitor | |||
| 0.049 | 0.03 | 0.049 | Opioid mu receptor agonist | |||
| 0.082 | 0.063 | 0.082 | Antineoplastic alkaloid | |||
| 0.022 | 0.004 | 0.022 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.056 | 0.038 | 0.056 | Carbonic anhydrase II inhibitor | |||
| 0.055 | 0.037 | 0.055 | DNA helicase inhibitor | |||
| 0.055 | 0.037 | 0.055 | CC chemokine 2 receptor antagonist | |||
| 0.053 | 0.036 | 0.053 | Opioid agonist | |||
| 0.03 | 0.012 | 0.03 | Prostaglandin EP2 agonist | |||
| 0.048 | 0.031 | 0.048 | Aldosterone antagonist | |||
| 0.024 | 0.008 | 0.024 | Cyclin T1 inhibitor | |||
| 0.076 | 0.059 | 0.1 | Interferon agonist | 0.1 0.029 CID_22827811 | CID_22827811 | |
| 0.072 | 0.055 | 0.072 | Alpha 2a adrenoreceptor antagonist | |||
| 0.028 | 0.012 | 0.028 | Complement factor 1s inhibitor | |||
| 0.021 | 0.006 | 0.021 | CC chemokine 9 receptor antagonist | |||
| 0.055 | 0.039 | 0.055 | Carbonic anhydrase I inhibitor | 0.048 0.045 CID_22827811 | ||
| 0.07 | 0.055 | 0.07 | Metalloproteinase-9 inhibitor | |||
| 0.11 | 0.094 | 0.11 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.055 | 0.039 | 0.055 | Cyclin B2 inhibitor | |||
| 0.039 | 0.023 | 0.039 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.023 | 0.007 | 0.036 | Antibiotic Anthracycline-like | 0.036 0.003 CID_22827811 | CID_22827811 | |
| 0.055 | 0.039 | 0.055 | Ribonucleotide reductase inhibitor | |||
| 0.038 | 0.023 | 0.038 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.049 | 0.034 | 0.049 | CC chemokine receptor 2B antagonist | |||
| 0.097 | 0.082 | 0.144 | Protein-tyrosine phosphatase 1B inhibitor | 0.144 0.048 CID_22827811 | CID_22827811 | |
| 0.053 | 0.038 | 0.053 | Ribonucleoside-diphosphate reductase inhibitor | |||
| 0.053 | 0.038 | 0.075 | Leukotriene B4 antagonist | 0.075 0.017 CID_22827811 | CID_22827811 | |
| 0.048 | 0.034 | 0.048 | Dopamine transporter inhibitor | |||
| 0.022 | 0.008 | 0.022 | Alpha 2b adrenoreceptor agonist | |||
| 0.027 | 0.013 | 0.027 | Prostaglandin E2 agonist | |||
| 0.062 | 0.048 | 0.08 | Interferon inducer | 0.08 0.023 CID_22827811 | CID_22827811 | |
| 0.021 | 0.007 | 0.021 | NMDA receptor phencyclidine site antagonist | |||
| 0.021 | 0.007 | 0.029 | Telomerase stimulant | 0.029 0.003 CID_22827811 | CID_22827811 | |
| 0.078 | 0.064 | 0.078 | I kappa B kinase inhibitor | |||
| 0.041 | 0.027 | 0.041 | Phenylethanolamine N methyltransferase inhibitor | |||
| 0.107 | 0.094 | 0.107 | Tubulin antagonist | |||
| 0.038 | 0.025 | 0.038 | Diamine oxidase inhibitor | |||
| 0.025 | 0.012 | 0.033 | Dopamine D1 agonist | 0.033 0.007 CID_22827811 | CID_22827811 | |
| 0.057 | 0.045 | 0.057 | Acetylcholine M3 receptor antagonist | |||
| 0.066 | 0.053 | 0.066 | HIV-1 reverse transcriptase inhibitor | |||
| 0.025 | 0.013 | 0.025 | Kainate receptor 1 antagonist | |||
| 0.05 | 0.038 | 0.129 | Factor IXa inhibitor | 0.129 0.005 CID_22827811 | CID_22827811 | |
| 0.056 | 0.045 | 0.076 | Lipocortins synthesis agonist | 0.076 0.016 CID_22827811 | CID_22827811 | |
| 0.043 | 0.031 | 0.043 | Nicotinic receptor alpha3 subunit antagonist | |||
| 0.029 | 0.017 | 0.029 | Lysine carboxypeptidase inhibitor | |||
| 0.016 | 0.004 | 0.016 | Thromboxane agonist | |||
| 0.056 | 0.045 | 0.078 | Prostaglandin EP2 antagonist | 0.078 0.028 CID_22827811 | CID_22827811 | |
| 0.02 | 0.009 | 0.02 | Complement factor D inhibitor | |||
| 0.088 | 0.078 | 0.088 | Alpha 2c adrenoreceptor antagonist | |||
| 0.048 | 0.038 | 0.048 | Dopamine D4 agonist | |||
| 0.05 | 0.04 | 0.05 | Prostaglandin antagonist | |||
| 0.049 | 0.039 | 0.049 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.014 | 0.004 | 0.014 | Progesterone receptor A antagonist | |||
| 0.032 | 0.022 | 0.032 | Cholesterol ester transfer protein antagonist | |||
| 0.026 | 0.016 | 0.026 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.015 | 0.005 | 0.015 | Egl nine homolog 3 inhibitor | |||
| 0.057 | 0.047 | 0.057 | Cyclin B1 inhibitor | |||
| 0.014 | 0.004 | 0.014 | Thyroid hormone beta agonist | |||
| 0.096 | 0.086 | 0.129 | Multidrug resistance-associated protein 1 inhibitor | 0.129 0.039 CID_22827811 | CID_22827811 | |
| 0.058 | 0.049 | 0.058 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.029 | 0.02 | 0.029 | 5 Hydroxytryptamine 6 agonist | |||
| 0.042 | 0.034 | 0.042 | Histamine H1 receptor agonist | |||
| 0.104 | 0.096 | 0.104 | M17 leucyl aminopeptidase inhibitor | |||
| 0.019 | 0.01 | 0.019 | G-protein-coupled receptor 120 agonist | |||
| 0.072 | 0.063 | 0.072 | Metalloproteinase-2 inhibitor | |||
| 0.037 | 0.029 | 0.037 | Glutamate (mGluR group II) antagonist | |||
| 0.043 | 0.034 | 0.043 | Oleamide hydrolase inhibitor | |||
| 0.05 | 0.042 | 0.05 | Vanilloid 2 antagonist | |||
| 0.041 | 0.034 | 0.041 | Liver X receptor agonist | |||
| 0.017 | 0.01 | 0.017 | Thyroid hormone alpha agonist | |||
| 0.053 | 0.046 | 0.053 | Alpha 1 adrenoreceptor agonist | |||
| 0.014 | 0.007 | 0.014 | Glutamate (mGluR6) agonist | |||
| 0.026 | 0.019 | 0.026 | Urotensin II agonist | |||
| 0.044 | 0.037 | 0.044 | Glycine transporter inhibitor | |||
| 0.024 | 0.017 | 0.024 | Glutamate (mGluR1) agonist | |||
| 0.028 | 0.022 | 0.028 | MAP3K8 inhibitor | |||
| 0.053 | 0.046 | 0.053 | EphB4 antagonist | |||
| 0.016 | 0.009 | 0.016 | Egl nine homolog 1 inhibitor | |||
| 0.015 | 0.008 | 0.015 | Integrin beta6 antagonist | |||
| 0.027 | 0.021 | 0.027 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.077 | 0.071 | 0.077 | Ca(v)3.1 blocker | |||
| 0.034 | 0.029 | 0.034 | 5-Alpha-reductase inhibitor | |||
| 0.059 | 0.054 | 0.059 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.016 | 0.01 | 0.016 | Purinergic P2Y1 agonist | |||
| 0.137 | 0.132 | 0.137 | Cyclin-dependent kinase 3 inhibitor | |||
| 0.009 | 0.004 | 0.009 | DNA topoisomerase III inhibitor | |||
| 0.041 | 0.036 | 0.041 | Purinergic P2Y antagonist | |||
| 0.107 | 0.102 | 0.107 | Sodium channel blocker | |||
| 0.057 | 0.052 | 0.057 | Bcl-xL inhibitor | |||
| 0.085 | 0.08 | 0.085 | Bronchodilator | |||
| 0.015 | 0.011 | 0.015 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | |||
| 0.036 | 0.032 | 0.036 | Dopamine D3 agonist | |||
| 0.018 | 0.014 | 0.018 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.019 | 0.016 | 0.019 | Imidazoline I1 receptor antagonist | |||
| 0.018 | 0.015 | 0.018 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | |||
| 0.06 | 0.058 | 0.06 | Nav1.7 sodium channel blocker | |||
| 0.056 | 0.053 | 0.056 | Phosphodiesterase 1A inhibitor | |||
| 0.053 | 0.05 | 0.053 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.042 | 0.039 | 0.042 | Glutamate (mGluR5) agonist | |||
| 0.049 | 0.047 | 0.049 | Cyclin B inhibitor | |||
| 0.014 | 0.012 | 0.014 | Thyroid hormone alpha antagonist | |||
| 0.015 | 0.013 | 0.015 | Antibiotic Tetracycline-like | |||
| 0.017 | 0.016 | 0.017 | Prostaglandin EP1 antagonist | |||
| 0.013 | 0.012 | 0.013 | Prostaglandin EP4 agonist | |||
| 0.019 | 0.018 | 0.019 | Aggrecanase 2 inhibitor | |||
| 0.006 | 0.004 | 0.006 | Insulin like growth factor 3 antagonist | |||
| 0.033 | 0.032 | 0.033 | Adenosine uptake inhibitor | |||
| 0.02 | 0.019 | 0.02 | Neuraminidase (Influenza B) inhibitor | |||
| 0.017 | 0.016 | 0.017 | Alpha 2c adrenoreceptor agonist | |||
| 0.13 | 0.132 | 0.481 | Platelet adhesion inhibitor | 0.481 0.006 CID_22827811 | CID_22827811 | |
| 0.008 | 0.011 | 0.013 | Purinergic P2Y2 agonist | 0.013 0.004 CID_22827811 | CID_22827811 | |
| 0.095 | 0.1 | 0.433 | Cell adhesion inhibitor | 0.433 0.005 CID_22827811 | CID_22827811 | |
| 0.141 | 0.147 | 0.381 | Hypolipemic | 0.381 0.029 CID_22827811 | CID_22827811 | |
| 0.066 | 0.073 | 0.073 | Phosphodiesterase VI inhibitor | 0.073 0.055 CID_22827811 | CID_22827811 | |
| 0.043 | 0.051 | 0.055 | Cytokine production stimulant | 0.055 0.018 CID_22827811 | CID_22827811 | |
| 0.011 | 0.023 | 0.032 | Ileal bile acid transport inhibitor | 0.032 0.005 CID_22827811 | CID_22827811 | |
| 0.023 | 0.041 | 0.032 | 1,3-Beta-glucan synthase inhibitor | 0.032 0.011 CID_22827811 | CID_22827811 | |
| 0.054 | 0.072 | 0.127 | Neuraminidase (influenza) inhibitor | 0.127 0.01 CID_22827811 | CID_22827811 | |
| 0.009 | 0.035 | 0.015 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.015 0.01 CID_22827811 | CID_22827811 | |
| 0.016 | 0.042 | 0.066 | Squalene synthetase inhibitor | 0.066 0.01 CID_22827811 | CID_22827811 | |
| 0.053 | 0.084 | 0.117 | Histone deacetylase SIRT1 stimulant | 0.117 0.019 CID_22827811 | CID_22827811 | |
| 0.053 | 0.084 | 0.117 | Histone deacetylase stimulant | 0.117 0.019 CID_22827811 | CID_22827811 | |
| 0.04 | 0.079 | 0.057 | Factor III inhibitor | 0.057 0.021 CID_22827811 | CID_22827811 | |
| 0.011 | 0.051 | 0.021 | Adenosine A1 receptor agonist | 0.021 0.02 CID_22827811 | CID_22827811 | |
| 0.038 | 0.079 | 0.477 | Selectin antagonist | 0.477 0.003 CID_22827811 | CID_22827811 | |
| 0.059 | 0.102 | 0.271 | Cell adhesion molecule inhibitor | 0.271 0.005 CID_22827811 | CID_22827811 | |
| 0.022 | 0.068 | 0.06 | Factor Xa inhibitor | 0.06 0.024 CID_22827811 | CID_22827811 | |
| 0.014 | 0.06 | 0.076 | Protein 30S ribosomal subunit inhibitor | 0.076 0.004 CID_22827811 | CID_22827811 | |
| 0.01 | 0.061 | 0.021 | Corticosteroid-like | 0.021 0.014 CID_22827811 | CID_22827811 | |
| 0.032 | 0.096 | 0.105 | Neuraminidase inhibitor | 0.105 0.014 CID_22827811 | CID_22827811 | |
| 0.034 | 0.111 | 0.254 | Antineoplastic antibiotic | 0.254 0.014 CID_22827811 | CID_22827811 | |
| 0.101 | 0.201 | 0.156 | P-glycoprotein inhibitor | 0.156 0.107 CID_22827811 | CID_22827811 | |
| 0.057 | 0.168 | 0.18 | Transcription factor NF kappa B stimulant | 0.18 0.011 CID_22827811 | CID_22827811 | |
| 0.02 | 0.15 | 0.095 | Antibiotic Aminoglycoside-like | 0.095 0.003 CID_22827811 | CID_22827811 | |
| 0.03 | 0.171 | 0.057 | Transcription factor AP-1 inhibitor | 0.057 0.05 CID_22827811 | CID_22827811 | |
| 0.019 | 0.163 | 0.062 | Neuraminidase (Influenza A) inhibitor | 0.062 0.012 CID_22827811 | CID_22827811 | |
| 0.019 | 0.166 | 0.141 | Protein 50S ribosomal subunit inhibitor | 0.141 0.007 CID_22827811 | CID_22827811 | |
| 0.058 | 0.208 | 0.379 | Thrombolytic | 0.379 0.013 CID_22827811 | CID_22827811 | |
| 0.002 | 0.151 | 0.017 | Antibiotic Macrolide-like | 0.017 0.008 CID_22827811 | CID_22827811 | |
| 0.095 | 0.257 | 0.36 | Vasodilator | 0.36 0.031 CID_22827811 | CID_22827811 | |
| 0.018 | 0.206 | 0.052 | Microtubule stabilization | 0.052 0.025 CID_22827811 | CID_22827811 | |
| 0.033 | 0.256 | 0.143 | DNA intercalator | 0.143 0.045 CID_22827811 | CID_22827811 | |
| 0.065 | 0.311 | 0.381 | Platelet antagonist | 0.381 0.031 CID_22827811 | CID_22827811 | |
| 0.048 | 0.309 | 0.317 | Anticoagulant | 0.317 0.026 CID_22827811 | CID_22827811 | |
| 0.067 | 0.333 | 0.473 | Tumour necrosis factor alpha release inhibitor | 0.473 0.017 CID_22827811 | CID_22827811 | |
| 0.018 | 0.292 | 0.072 | DNA gyrase inhibitor | 0.072 0.034 CID_22827811 | CID_22827811 | |
| 0.016 | 0.348 | 0.074 | Nitric oxide donor | 0.074 0.028 CID_22827811 | CID_22827811 | |
| 0.012 | 0.413 | 0.037 | Toll-Like receptor 4 agonist | 0.037 0.005 CID_22827811 | CID_22827811 | |
| 0.058 | 0.463 | 0.286 | Angiogenesis inhibitor | 0.286 0.1 CID_22827811 | CID_22827811 | |
| 0.064 | 0.505 | 0.53 | Immunomodulator | 0.53 0.019 CID_22827811 | CID_22827811 | |
| 0.004 | 0.508 | 0.017 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.017 0.012 CID_22827811 | CID_22827811 | |
| 0.004 | 0.705 | 0.025 | Motilin receptor agonist | 0.025 0.013 CID_22827811 | CID_22827811 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |